Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells
- 30 June 2007
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 19 (6) , 1172-1184
- https://doi.org/10.1016/j.cellsig.2006.12.008
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- TRAIL promotes metastasis of human pancreatic ductal adenocarcinomaOncogene, 2006
- Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Nonapoptotic functions of FADD-binding death receptors and their signaling moleculesCurrent Opinion in Cell Biology, 2005
- CD95 and TRAF2 promote invasiveness of pancreatic cancer cellsThe FASEB Journal, 2005
- CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cellsThe EMBO Journal, 2004
- TRAIL Induces Apoptosis and Inflammatory Gene Expression in Human Endothelial CellsThe Journal of Immunology, 2003
- Non-apoptotic Fas signalingCytokine & Growth Factor Reviews, 2002
- Modulation of Tumor Necrosis Factor Apoptosis-inducing Ligand- induced NF-κB Activation by Inhibition of Apical CaspasesPublished by Elsevier ,2001
- CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-κB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cellsOncogene, 2001
- Inhibition of Death Receptor-mediated Gene Induction by a Cycloheximide-sensitive Factor Occurs at the Level of or Upstream of Fas-associated Death Domain Protein (FADD)Published by Elsevier ,2000